Omeros reported $611K in Ordinary Share Capital for its fiscal quarter ending in December of 2023.





Ordinary Share Capital Change Date
Adma Biologics USD 237.88M 457K Dec/2025
Alnylam Pharmaceuticals USD 133.44M 1.07M Mar/2026
BioMarin Pharmaceutical USD 193.27M 969K Mar/2026
Cytokinetics USD 124.43M 2.17M Mar/2026
Gilead Sciences USD 1.24B 1000K Mar/2026
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Immunic USD 120.38M 21.73M Dec/2025
Insmed USD 216.52M 2.27M Mar/2026
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
MacroGenics USD 63.32M 60K Dec/2025
Omeros USD 611K 17K Dec/2023
Pacira USD 39.31M 1.81M Mar/2026
Pfizer USD 5.7B 13M Mar/2026
Sarepta Therapeutics USD 105.57M 607K Mar/2026
United Therapeutics USD 42.16M 1.49M Mar/2026
Vertex Pharmaceuticals USD 254.2M 200K Mar/2026
Xoma USD 87K 1000 Jun/2024